John Siebert
Directeur/Membre du Conseil chez SUPERNUS PHARMACEUTICALS, INC.
Fortune : 2 M $ au 31/05/2024
Profil
Dr. John M.
Siebert is an Independent Director at Supernus Pharmaceuticals, Inc. He is on the Board of Directors at Supernus Pharmaceuticals, Inc., Accu-Break Pharmaceuticals, Inc., Primus Pharmaceuticals, Inc. and Riverside Pharmaceuticals Corp.
Dr. Siebert was previously employed as a President & Chief Executive Officer by Chase Pharmaceuticals Corp., a Chief Operating Officer & Partner by New Rhein Healthcare Investors, a Chairman & Chief Executive Officer by Compan Pharmaceuticals LLC, an Executive Chairman, Chief Executive Officer & CFO by Aradigm Corp., a Chairman & Chief Executive Officer by CyDex Pharmaceuticals, Inc., a President & Chief Executive Officer by CIMA Labs, Inc., a Vice President-Technical Affairs by Dey Laboratories, Inc., and a Head-Research & Development Division by Bayer Corp.
He also served on the board at SoluBest Ltd.
He received his undergraduate degree from Benedictine University, a graduate degree from Wichita State University and a doctorate degree from the University of Missouri.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/04/2024 | 87 943 ( 0,16% ) | 2 M $ | 31/05/2024 |
Postes actifs de John Siebert
| Sociétés | Poste | Début |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2011 |
Primus Pharmaceuticals, Inc.
 Primus Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Primus Pharmaceuticals, Inc. provides prescription metabolic products to physicians and patients throughout North America. It offers prescription drug and medical food products. Its products include Alcortin A, Novacort, Fosteum, and Limbrel. The company was founded by Michael J. Martin and is headquartered in Scottsdale, AZ. | Directeur/Membre du Conseil | - |
Accu-Break Pharmaceuticals, Inc.
 Accu-Break Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accu-Break Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm develops tablets that are designed to improve and enhance the functionality of pharmaceutical tablets. The company was founded in 2001 by Lawrence Solomon and David Lucking headquartered in Plantation, FL. | Directeur/Membre du Conseil | - |
| Riverside Pharmaceuticals Corp. | Directeur/Membre du Conseil | - |
Anciens postes connus de John Siebert
| Sociétés | Poste | Fin |
|---|---|---|
| ARADIGM CORPORATION | Directeur Général | 15/02/2019 |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Directeur Général | 01/11/2015 |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Directeur des opérations | 01/01/2014 |
| Compan Pharmaceuticals LLC | Directeur Général | 01/01/2010 |
CyDex Pharmaceuticals, Inc.
 CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Directeur Général | 13/10/2008 |
Formation de John Siebert
| University of Missouri | Doctorate Degree |
| Benedictine University | Undergraduate Degree |
| Wichita State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
CyDex Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CyDex Pharmaceuticals, Inc. provides pharmaceutical discovery, development and manufacturing services. Its product Captisol is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE). The firm engages in technology with substantial characterization, safety documentation and regulatory review. The company was founded in 1990 and is headquartered in San Diego, CA. | Health Technology |
Primus Pharmaceuticals, Inc.
Primus Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Primus Pharmaceuticals, Inc. provides prescription metabolic products to physicians and patients throughout North America. It offers prescription drug and medical food products. Its products include Alcortin A, Novacort, Fosteum, and Limbrel. The company was founded by Michael J. Martin and is headquartered in Scottsdale, AZ. | Retail Trade |
Accu-Break Pharmaceuticals, Inc.
Accu-Break Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accu-Break Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm develops tablets that are designed to improve and enhance the functionality of pharmaceutical tablets. The company was founded in 2001 by Lawrence Solomon and David Lucking headquartered in Plantation, FL. | Health Technology |
SoluBest Ltd.
 SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | Health Technology |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
| Dey Laboratories, Inc. | |
| Compan Pharmaceuticals LLC | |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors LLC (New Rhein Healthcare Investors) is a private equity firm founded in 2010 by Parekh Greg. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
| Riverside Pharmaceuticals Corp. | Miscellaneous |
